Renee Chan, MD
Obstetrics & Gynecology · McKinney, TXNPI 1952502999
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Mimedx Group, Inc. at 58.6% of the total. 2025 is the largest year on record at $3,147, more than ten times the $313 reported in 2019.
Across 144 payments — averaging $45.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$4K
- AbbVie$853
- Exeltis, USA Inc.$235
- Astellas Pharma US Inc$231
- Millicent US Inc$157
- Bayer$129
- plus $1K from 25 others
What the payments were for
- Consulting fees$3,80059%
- Food & beverage$2,66841%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 13 | $3,800 |
| AbbVie(2 entities) | 47 | $853 |
| Exeltis, USA Inc. | 12 | $235 |
| Astellas Pharma US Inc | 6 | $231 |
| Millicent US Inc | 3 | $157 |
| Bayer | 7 | $129 |
| Aspira Women's Health Inc | 5 | $129 |
| Organon | 4 | $105 |
| Mission Pharmacal Company | 5 | $83 |
| Pfizer | 3 | $68 |
| Lupin Inc. | 4 | $61 |
| Coopersurgical, Inc. | 3 | $59 |
| Sage Therapeutics, LLC | 3 | $47 |
| Minerva Surgical, Inc | 3 | $45 |
| Meditrina | 3 | $43 |
| Abiomed | 1 | $42 |
| Myovant Sciences Inc. | 2 | $40 |
| Abbott | 2 | $37 |
| Avanos Medical | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Innovation Technologies Inc | 1 | $35 |
| Agile Therapeutics, Inc. | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $29 |
| Evofem Biosciences, Inc. | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Sanofi | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Acessa Health Inc. | 1 | $15 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$400
- Veozah$123
- INTRAROSA$118
How this compares
$6,480 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 22 | $802 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in McKinney
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.